Work

Transforming the clinical trial process: The I-SPY 2 trial as a model for improving the efficiency of clinical trials and accelerating the drug-screening process.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.tps2633

Authors: Meredith B. Buxton, Kelsey Natsuhara, Angela DeMichele, Jane Perlmutter, Nola M Hylton, Douglas Yee, Laura van't Veer, William Fraser Symmans, Michael Hogarth, Julia Lyandres, Sarah E Davis, Susan Flynn, Melissa Paoloni, Donald A. Berry, Laura Esserman, I-SPY 2 TRIAL Investigators

Institutions: University of California, San Francisco, Abramson Cancer Center, University of Pennsylvania, University of Minnesota, Masonic Cancer Center, The University of Texas MD Anderson Cancer Center, University of California, Davis, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600548649

Cites:

Cited by: 3

Related to: 10